Health
Study addresses glycosylation concerns in SARS-CoV-2 vaccine design – News-Medical.Net
An international team of researchers has found that glycosylation patterns are conserved across the native spike protein of severe acute respiratory syndrome coronavirus…
An international team of researchers has found that glycosylation patterns are conserved across the native spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – and the recombinant spike proteins made in laboratories for use in vaccines.
The spike protein, which SARS-CoV-2 uses to bind to and infect cells, is the main target of neutralizing antibodies following natural infection with the virus or vaccination.
A…
-
General19 hours agoGerman backpacker Carolina Wilga found alive in WA’s outback
-
Noosa News22 hours agoAustralian NFL player Laki Tasi comes home to convince kids to switch codes
-
Business21 hours agoHow $1,000 a month in this ASX ETF could turn into $500,000
-
Noosa News21 hours agoInside the final hours before Australian lawyer Christopher Saines died in Thai massage parlour